Scarica l'app Stockscreener
0.9409
4.77%
-0.0471
Calcimedica Inc Borsa (CALC) Ultime notizie
Form 13D/A CALCIMEDICA For: 30 June By Investing.com - Investing.com Canada
CalciMedica (CALC) insiders add shares via open-market and unit purchases - Stock Titan
Form 4 CalciMedica Inc For: 29 June By Investing.com - Investing.com South Africa
Calcimedica director Fred Middleton acquires $199,999 in stock. - Investing.com
Calcimedica director Fred Middleton acquires $199,999 in stock. By Investing.com - Investing.com Canada
CalciMedica (CALC) chief business officer gets 186,729-share stock award at $0.8033 - Stock Titan
CalciMedica (CALC) insider-affiliated fund buys 248,972 new shares at $0.8033 - Stock Titan
FDA raises no concerns over Auxora safety data, CalciMedica advances trial - MSN
CalciMedica (NASDAQ: CALC) lenders capped at 4.99% ownership after loan amendment - Stock Titan
Key facts: CalciMedica $15M raise; Auxora paused, FDA feedback due Q3 - TradingView
CalciMedica Receives FDA Clearance to Resume Auxora Clinical Trial for Acute Kidney Injury After Safety Review - Minichart
CalciMedica Announces Private Placement Financing for Up to About $49M to Advance Pulmonary Hypertension Program - Moomoo
CalciMedica Advances Auxora After Favorable FDA Safety Review - TipRanks
CalciMedica (Nasdaq: CALC) raises $15M, maps PAH and PH trial plans - Stock Titan
H.C. Wainwright Maintains CalciMedica(CALC.US) With Hold Rating - Moomoo
CalciMedica says FDA allows KOURAGE trial to continue - grafa.com
CalciMedica receives FDA clearance to continue Auxora trial By Investing.com - Investing.com Australia
CalciMedica, Inc. Announces Amendments to Loan and Warrant Agreements with Avenue Venture Opportunities Fund II, L.P – Minichart - Minichart
$CalciMedica (CALC.US)$ - Moomoo
What's Going On With CalciMedica Stock Wednesday?CalciMedica (NASDAQ:CALC) - Benzinga
CalciMedica secures up to $49M private placement financing - Investing.com
CalciMedica receives FDA clearance to continue Auxora trial - Investing.com
CalciMedica: Proceeds Expected to Support Pulmonary Hypertension Strategy, Including Phase 1b POC Study Evaluating Auxora in PAH, With Data Anticipated Mid-2027, and Advancement of Oral CRAC Channel Inhibitor CM5480 to IND Clearance Expecte - Moomoo
CalciMedica Says Auxora Phase 2 Trial May Continue Dosing After FDA Review - marketscreener.com
CalciMedica to Sell 18.7M Units >CALC - Moomoo
CalciMedica Announces Clinical Development of Auxora May Proceed Following FDA Review of KOURAGE Trial Interim Safety Data - The AI Journal
CalciMedica Entered Into Definitive Securities Purchase Agreement With Leading Healthcare Investors >CALC - Moomoo
CalciMedica Amends Loan, Issues New Equity Warrants - TipRanks
Calcimedica Announces Private Placement Financing For Up To Approximately $49 Million To Advance Pulmonary Hypertension Program - TradingView
Press Release: CalciMedica Announces Private Placement Financing for Up to Approximately $49 Million to Advance Pulmonary Hypertension Program - Moomoo
CalciMedica Extends $10M Loan, Adds $3M Conversion; Issues New $1.00 Warrants - TradingView
CalciMedica (NASDAQ: CALC) extends Avenue loan and issues new $1.00 warrants - Stock Titan
CalciMedica Inc (CALC) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
CALC News | CALCIMEDICA INC (NASDAQ:CALC) - ChartMill
CalciMedica Inc (CALC) Valuation: PE, PB & Fair Value Analysis - TradingKey
CalciMedica Inc (CALC) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
CalciMedica Inc (CALC) Institutional Confidence - TradingKey
CalciMedica Inc (CALC) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
CalciMedica Inc (CALC) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
CalciMedica Inc (CALC) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
CalciMedica Inc (CALC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
CalciMedica Inc (CALC) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
CalciMedica (CALC) Holds Steady Above $0.83 Support After Nearly Flat SessionPercent Above MA - newsline.com
CalciMedica (CALC) Slips 2.75% as Stock Tests Key Support LevelsVolatility Breakout Picks - newsline.com
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
CALC Q1 2026 Earnings: Surprising Profitability Amid No RevenueHigh Growth Earnings - newsline.com
CALC Stock Chart | CALCIMEDICA INC (NASDAQ:CALC) - ChartMill
CALC Q1 2026 Earnings: Surprise Profit Amid Pre-Revenue Pipeline ProgressPost-Earnings Drift - newsline.com
CalciMedica (CALC) Slips 6%: Support Level Holds Key to RecoveryCTA Positioning - newsline.com
CALCCalciMedica Inc Stock Price and Quote - Finviz
CalciMedica (CALC) Faces Selling Pressure Near Support as Biotech Uncertainty PersistsRevenue Weighted - newsline.com
CALC Q1 2026 Earnings: Surprising Profit on a Per‑Share Basis, Yet Shares DeclineOne-Time Loss Impact - thelegaladvocate.com
CalciMedica (CALC) Edges Lower, Approaching Critical Support at $0.70PCR Mean Reversion - The Legal Advocate
CalciMedica (CALC) Holds Near Support as Price Movement Remains MinimalTotal Put Call - newsline.com
Number of shareholders of CalciMedica, Inc. – NASDAQ:CALC - TradingView
CALC Q1 2026 Earnings: EPS Misses Estimates Amid Ongoing Clinical-Stage InvestmentsDividend Growth Analysis - Město Břeclav
1.16%
0.48%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):